Comments
Loading...

Travere Therapeutics Short Interest Report

TVTXNASDAQ
Logo brought to you by Benzinga Data
$34.51
-0.50-1.43%
Last update: Dec 12, 9:27 AM

Travere Therapeutics Stock Short Interest Report | NASDAQ:TVTX | Benzinga

Short interest in Travere Therapeutics Inc (NASDAQ:TVTX) increased during the last reporting period, rising from 10.36M to 10.97M. This put 12.35% of the company's publicly available shares short.

Based on the recent average volume of 1.31M shares traded per day, it would take 8.35 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.

Short Interest
10.97M
Short Interest %
12.3%
Days to Cover
8.35
Get Alert
TVTXTravere Therapeutics, Inc. Com11/28/202512/09/202512.35%88,851,35210,969,7221,313,8978.35Get Alert
TVTXTravere Therapeutics, Inc. Com11/14/202511/25/202511.66%88,851,35210,355,8082,152,4924.81Get Alert
TVTXTravere Therapeutics, Inc. Com10/31/202511/11/202512.24%88,851,35210,879,5062,183,3114.98Get Alert
TVTXTravere Therapeutics, Inc. Com10/15/202510/24/202513.38%88,517,69811,840,3401,631,8937.26Get Alert
TVTXTravere Therapeutics, Inc. Com09/30/202510/09/202512.70%88,517,69811,241,9682,111,3485.32Get Alert
TVTXTravere Therapeutics, Inc. Com09/15/202509/24/202513.92%88,517,69812,319,2823,781,6603.26Get Alert
TVTXTravere Therapeutics, Inc. Com08/29/202509/10/202513.65%88,517,69812,081,7471,650,5367.32Get Alert
TVTXTravere Therapeutics, Inc. Com08/15/202508/26/202513.68%88,517,69812,107,7461,713,4337.07Get Alert
TVTXTravere Therapeutics, Inc. Com07/31/202508/11/202512.00%88,517,69810,624,3781,168,6219.09Get Alert
TVTXTravere Therapeutics, Inc. Com07/15/202507/24/202516.02%80,268,58212,859,5891,297,6259.91Get Alert
TVTXTravere Therapeutics, Inc. Com06/30/202507/10/202515.57%80,268,58212,499,8831,530,6598.17Get Alert
TVTXTravere Therapeutics, Inc. Com06/13/202506/25/202512.87%80,268,58210,329,3111,586,8516.51Get Alert
TVTXTravere Therapeutics, Inc. Com05/30/202506/10/202515.58%80,268,58212,502,3672,149,4645.82Get Alert
TVTXTravere Therapeutics, Inc. Com05/15/202505/27/202513.00%80,268,58210,434,6821,704,0416.12Get Alert
TVTXTravere Therapeutics, Inc. Com04/30/202505/09/202513.25%80,268,58210,637,7551,401,7507.59Get Alert
TVTXTravere Therapeutics, Inc. Com04/15/202504/25/202513.76%80,268,58211,046,1072,146,1905.15Get Alert
TVTXTravere Therapeutics, Inc. Com03/31/202504/09/202514.40%80,268,58211,556,8121,632,7317.08Get Alert
TVTXTravere Therapeutics, Inc. Com03/14/202503/25/202513.95%80,268,58211,194,8401,567,8617.14Get Alert
TVTXTravere Therapeutics, Inc. Com02/28/202503/11/202513.64%80,268,58210,948,5501,782,5626.14Get Alert
TVTXTravere Therapeutics, Inc. Com02/14/202502/26/202514.08%80,268,58211,301,6362,269,8184.98Get Alert
TVTXTravere Therapeutics, Inc. Com01/31/202502/11/202512.16%78,563,0599,555,7551,277,3447.48Get Alert
TVTXTravere Therapeutics, Inc. Com01/15/202501/27/202512.19%78,563,0599,577,1541,215,5207.88Get Alert
TVTXTravere Therapeutics, Inc. Com12/31/202401/10/202511.10%78,563,0598,719,3871,356,7936.43Get Alert
TVTXTravere Therapeutics, Inc. Com12/13/202412/24/20249.43%78,563,0597,405,7691,061,5156.98Get Alert
TVTXTravere Therapeutics, Inc. Com11/29/202412/10/20249.64%78,563,0597,574,9471,178,7026.43Get Alert
TVTXTravere Therapeutics, Inc. Com11/15/202411/26/20248.87%78,563,0596,971,4851,545,8574.51Get Alert
TVTXTravere Therapeutics, Inc. Com10/31/202411/11/202411.75%68,020,2417,991,2291,148,9566.96Get Alert
TVTXTravere Therapeutics, Inc. Com10/15/202410/24/202411.92%68,020,2418,107,7202,956,6432.74Get Alert
TVTXTravere Therapeutics, Inc. Com09/30/202410/09/202410.24%68,020,2416,962,0902,344,3212.97Get Alert
TVTXTravere Therapeutics, Inc. Com09/13/202409/24/202412.73%68,020,2418,657,1112,582,9023.35Get Alert
TVTXTravere Therapeutics, Inc. Com08/30/202409/11/202413.60%68,020,2419,253,644693,68513.34Get Alert
TVTXTravere Therapeutics, Inc. Com07/31/202408/09/202414.83%68,020,24110,085,762969,30010.41Get Alert
TVTXTravere Therapeutics, Inc. Com07/15/202407/24/202414.93%67,657,77410,099,2331,182,3738.54Get Alert
TVTXTravere Therapeutics, Inc. Com06/28/202407/10/202415.25%67,657,77410,320,6661,761,1215.86Get Alert
TVTXTravere Therapeutics, Inc. Com06/14/202406/26/202419.83%67,657,77413,414,704837,54516.02Get Alert
TVTXTravere Therapeutics, Inc. Com05/31/202406/11/202419.90%67,657,77413,466,6781,040,84312.94Get Alert
TVTXTravere Therapeutics, Inc. Com05/15/202405/24/202419.87%67,657,77413,441,0291,209,99211.11Get Alert
TVTXTravere Therapeutics, Inc. Com04/30/202405/09/202418.94%67,657,77412,811,0951,373,4049.33Get Alert
TVTXTravere Therapeutics, Inc. Com04/15/202404/24/202417.45%67,637,58511,802,1981,352,7248.72Get Alert
TVTXTravere Therapeutics, Inc. Com03/28/202404/09/202415.67%67,637,58510,601,943988,08110.73Get Alert
TVTXTravere Therapeutics, Inc. Com03/15/202403/26/202413.30%75,730,59910,071,6521,191,6488.45Get Alert
TVTXTravere Therapeutics, Inc. Com02/29/202403/11/202413.55%75,730,59910,260,8921,290,4107.95Get Alert
TVTXTravere Therapeutics, Inc. Com01/31/202402/09/202413.28%74,777,9459,930,2521,313,1367.56Get Alert
TVTXTravere Therapeutics, Inc. Com01/12/202401/24/202412.98%74,777,9459,706,8531,596,1726.08Get Alert
TVTXTravere Therapeutics, Inc. Com12/29/202301/10/202413.27%74,777,9459,919,3151,209,3948.2Get Alert
TVTXTravere Therapeutics, Inc. Com12/15/202312/27/202312.90%74,777,9459,644,7672,292,3584.21Get Alert